range of investments. The Company’s gains and return on financial instruments were derived from a variety of products, including, derivative warrants (DWs), over-the-counter (OTC) derivatives, investments
overseas customer and management’s effort to diversify into more higher value product range led to higher revenues. Thailand operations were very strong; recording 22.4% growth year-on-year. Portugal
from the momentum of Babi Mild Sweet Almond range launched in Q2’19, and on top with the new products launches in Q3’19, including Twelve Plus whitening plus roll on and Twelve Plus perfume card. Joint
personal care revenues recorded at THB 678 million, an increase of 0.5% YoY). The growth driver were the continued success of Babi Mild from the momentum of Babi Mild Sweet Almond range launched in Q2’19 and
for the use of spectrum, towers, and equipment. Overall, we expect the consolidated EBITDA margin to improve and stay in the range of 42-44%. The total cash CAPEX (excluding spectrum payment) is
in all businesses. As a result, we expect EBITDA margin (EBITDA over total revenue) to be stable from last year (43.4% in 2018). With the full range of spectrum portfolio in 900/1800/2100MHz to support
granted by the Securities and Exchange Commission) in the range of 321,470,000 Baht to 373,510,00 Baht. As of 6 November 2019, the Company has an investment in YLP in the amount of 170,000,000 Baht. Basis
business and the growth of associates company, Singer Thailand. This has an outstanding performance growth. In addition, the company can plan operations, reduce operating costs to get through the range of
การ อนุญาตให้ออกและเสนอขายหุ้นกูท่ี้มีอนุพนัธ์แฝง แบบ 69-SP (ส่วนท่ี 1 : แบบ 69-SP-1) สามารถเลือกยืน่แบบแสดงรายการขอ้มูล โดยระบุขอ้มูลดงัต่อไปน้ี เป็นช่วง (range) ขอ้มูลตวัเลขสูงสุด (maximum) หรือ ขอ้
Thailand’s target range of 1-4 percent. At the same time, core inflation was at 0.61 percent, a slight decrease from 0.66 percent in the same period last year, reflecting a gradual recovery in domestic